1. Home
  2. RMNI vs CERS Comparison

RMNI vs CERS Comparison

Compare RMNI & CERS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rimini Street Inc. (DE)

RMNI

Rimini Street Inc. (DE)

HOLD

Current Price

$3.98

Market Cap

307.1M

ML Signal

HOLD

Logo Cerus Corporation

CERS

Cerus Corporation

HOLD

Current Price

$2.69

Market Cap

276.0M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
RMNI
CERS
Founded
2005
1991
Country
United States
United States
Employees
N/A
N/A
Industry
Business Services
EDP Services
Sector
Consumer Discretionary
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
307.1M
276.0M
IPO Year
2015
1996

Fundamental Metrics

Financial Performance
Metric
RMNI
CERS
Price
$3.98
$2.69
Analyst Decision
Buy
Analyst Count
3
0
Target Price
$5.00
N/A
AVG Volume (30 Days)
305.1K
949.4K
Earning Date
04-30-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
197.50
27.27
EPS
0.01
N/A
Revenue
$431,496,000.00
$51,326,000.00
Revenue This Year
$6.02
$19.95
Revenue Next Year
$5.50
$8.84
P/E Ratio
$8.74
N/A
Revenue Growth
5.33
30.68
52 Week Low
$2.87
$1.15
52 Week High
$5.38
$2.96

Technical Indicators

Market Signals
Indicator
RMNI
CERS
Relative Strength Index (RSI) 69.61 78.89
Support Level $3.91 $1.84
Resistance Level $4.15 $2.96
Average True Range (ATR) 0.13 0.14
MACD 0.02 0.05
Stochastic Oscillator 85.63 68.85

Price Performance

Historical Comparison
RMNI
CERS

About RMNI Rimini Street Inc. (DE)

Rimini Street Inc and its subsidiaries are providers of end-to-end enterprise software support, products, and services. The company offers a comprehensive family of unified solutions to run, manage, support, customize, configure, connect, protect, monitor, and optimize clients' enterprise applications, databases, and technology software platforms. The company derives revenues from clients by providing subscription support services for enterprise resource planning, customer relationship management, product lifecycle management, database, and technology software systems. Geographically, the company generates its revenue from the United States of America and the International market.

About CERS Cerus Corporation

Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety and generates revenue from the same.

Share on Social Networks: